Industry Research Reports

Home > Reports > Pharma & Healthcare > Global and Japan Hyperimmune Globulins Market Report & Forecast 2024-2030

Global and Japan Hyperimmune Globulins Market Report & Forecast 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-09-05

Pages: 128 Pages

Report ld: 3311600

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Hyperimmune Globulins Market Size(US$)

CAGR 2024-2030

Market Size,2030

USD 2,906

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 1,936 million

Market Forecast in 2030(Value)

US$ 2,906 million

CAGR

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously. Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

The global Hyperimmune Globulins revenue was US$ 1822 million in 2023 and is forecast to a readjusted size of US$ 2906 million by 2030 with a CAGR of 7.0% during the review period (2024-2030).

In Japan the Hyperimmune Globulins revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and Japan Hyperimmune Globulins market, also covers the segmentation data of other regions in regional level and county level.

Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%. Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent. In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

The hyperimmune globulin market is primarily driven by the increasing prevalence of infectious diseases and the rising demand for immunoglobulin therapies. These therapies are crucial in treating immunodeficiency disorders and providing passive immunity against various pathogens, which fuels market growth. Additionally, advancements in plasma-derived therapies and increasing government initiatives for immunization programs contribute to market expansion.

However, the market faces significant challenges, such as the high cost of treatment and limited availability of plasma, which is a critical raw material for hyperimmune globulin production. Moreover, stringent regulatory requirements for product approval and potential side effects associated with immunoglobulin therapies can hinder market growth.

Hyperimmune Globulins market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Hyperimmune Globulins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For Japan market, this report focuses on the Hyperimmune Globulins market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in Japan.

MARKET SEGMENTATION

By Company

CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Herpes Zoster Immune Globulin
Other

Segment by Application

Government Institutions
Private Sector
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces Hyperimmune Globulins definition, global sales (volume and revenue), Japan market size, Japan percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of Hyperimmune Globulins companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue and volume of Hyperimmune Globulins in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hyperimmune Globulins sales, revenue, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 12: research findings and conclusion

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Hyperimmune Globulins Product Introduction

1.2 Global Hyperimmune Globulins Outlook 2019 VS 2023 VS 2030

1.2.1 Global Hyperimmune Globulins Sales in US$ Million for the Year 2019-2030

1.2.2 Global Hyperimmune Globulins Sales in Volume for the Year 2019-2030

1.3 Japan Hyperimmune Globulins Outlook 2019 VS 2023 VS 2030

1.3.1 Japan Hyperimmune Globulins Sales in US$ Million for the Year 2019-2030

1.3.2 Japan Hyperimmune Globulins Sales in Volume for the Year 2019-2030

1.4 Hyperimmune Globulins Market Size, Japan VS Global, 2019 VS 2023 VS 2030

1.4.1 The Market Share of Japan Hyperimmune Globulins in Global, 2019 VS 2023 VS 2030

1.4.2 The Growth Rate of Hyperimmune Globulins Market Size, Japan VS Global, 2019 VS 2023 VS 2030

1.5 Hyperimmune Globulins Market Dynamics

1.5.1 Hyperimmune Globulins Industry Trends

1.5.2 Hyperimmune Globulins Market Drivers

1.5.3 Hyperimmune Globulins Market Challenges

1.5.4 Hyperimmune Globulins Market Restraints

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Hyperimmune Globulins by Type

2.1 Hyperimmune Globulins Market by Type

2.1.1 Hepatitis B Immunoglobulins

2.1.2 Rabies Immunoglobulins

2.1.3 Tetanus Immunoglobulins

2.1.4 Rho(D) Immunoglobulins

2.1.5 Herpes Zoster Immune Globulin

2.1.6 Other

2.2 Global Hyperimmune Globulins Market Size by Type

2.2.1 Global Hyperimmune Globulins Sales in Value, by Type (2019, 2023 & 2030)

2.2.2 Global Hyperimmune Globulins Sales in Volume, by Type (2019, 2023 & 2030)

2.2.3 Global Hyperimmune Globulins Average Selling Price (ASP) by Type (2019, 2023 & 2030)

2.3 Japan Hyperimmune Globulins Market Size by Type

2.3.1 Japan Hyperimmune Globulins Sales in Value, by Type (2019, 2023 & 2030)

2.3.2 Japan Hyperimmune Globulins Sales in Volume, by Type (2019, 2023 & 2030)

2.3.3 Japan Hyperimmune Globulins Average Selling Price (ASP) by Type (2019, 2023 & 2030)

3 Hyperimmune Globulins by Application

3.1 Hyperimmune Globulins Market by Application

3.1.1 Government Institutions

3.1.2 Private Sector

3.1.3 Other

3.2 Global Hyperimmune Globulins Market Size by Application

3.2.1 Global Hyperimmune Globulins Sales in Value, by Application (2019, 2023 & 2030)

3.2.2 Global Hyperimmune Globulins Sales in Volume, by Application (2019, 2023 & 2030)

3.2.3 Global Hyperimmune Globulins Average Selling Price (ASP) by Application (2019, 2023 & 2030)

3.3 Japan Hyperimmune Globulins Market Size by Application

3.3.1 Japan Hyperimmune Globulins Sales in Value, by Application (2019, 2023 & 2030)

3.3.2 Japan Hyperimmune Globulins Sales in Volume, by Application (2019, 2023 & 2030)

3.3.3 Japan Hyperimmune Globulins Average Selling Price (ASP) by Application (2019, 2023 & 2030)

4 Global Hyperimmune Globulins Competitor Landscape by Company

4.1 Global Hyperimmune Globulins Market Size by Company

4.1.1 Global Key Manufacturers of Hyperimmune Globulins, Ranked by Revenue (2023)

4.1.2 Global Hyperimmune Globulins Revenue by Manufacturer (2019-2024)

4.1.3 Global Hyperimmune Globulins Sales by Manufacturer (2019-2024)

4.1.4 Global Hyperimmune Globulins Price by Manufacturer (2019-2024)

4.2 Global Hyperimmune Globulins Concentration Ratio (CR)

4.2.1 Hyperimmune Globulins Market Concentration Ratio (CR) (2019-2024)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hyperimmune Globulins in 2023

4.2.3 Global Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Hyperimmune Globulins, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Hyperimmune Globulins, Product Offered and Application

4.5 Global Key Manufacturers of Hyperimmune Globulins, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 Japan Hyperimmune Globulins Market Size by Company

4.7.1 Key Players of Hyperimmune Globulins in Japan, Ranked by Revenue (2023)

4.7.2 Japan Hyperimmune Globulins Revenue by Players (2019-2024)

4.7.3 Japan Hyperimmune Globulins Sales by Players (2019-2024)

5 Global Hyperimmune Globulins Market Size by Region

5.1 Global Hyperimmune Globulins Market Size by Region: 2019 VS 2023 VS 2030

5.2 Global Hyperimmune Globulins Market Size in Volume by Region (2019-2030)

5.2.1 Global Hyperimmune Globulins Sales in Volume by Region: 2019-2024

5.2.2 Global Hyperimmune Globulins Sales in Volume Forecast by Region (2025-2030)

5.3 Global Hyperimmune Globulins Market Size in Value by Region (2019-2030)

5.3.1 Global Hyperimmune Globulins Sales in Value by Region: 2019-2024

5.3.2 Global Hyperimmune Globulins Sales in Value by Region: 2025-2030

6 Americas

6.1 Americas Hyperimmune Globulins Market Size YoY Growth 2019-2030

6.2 Americas Hyperimmune Globulins Sales in Volume, by Type (2019, 2023 & 2030)

6.3 Americas Hyperimmune Globulins Sales in Volume, by Application (2019, 2023 & 2030)

6.4 Americas Hyperimmune Globulins Market Facts & Figures by Country (2019, 2023 & 2030)

6.4.1 Americas Hyperimmune Globulins Sales in Value by Country (2019, 2023 & 2030)

6.4.2 Americas Hyperimmune Globulins Sales in Volume by Country (2019, 2023 & 2030)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Hyperimmune Globulins Market Size YoY Growth 2019-2030

7.2 EMEA Hyperimmune Globulins Sales in Volume, by Type (2019, 2023 & 2030)

7.3 EMEA Hyperimmune Globulins Sales in Volume, by Application (2019, 2023 & 2030)

7.4 EMEA Hyperimmune Globulins Market Facts & Figures by Country (2019, 2023 & 2030)

7.4.1 EMEA Hyperimmune Globulins Sales in Value by Country (2019, 2023 & 2030)

7.4.2 EMEA Hyperimmune Globulins Sales in Volume by Country (2019, 2023 & 2030)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Hyperimmune Globulins Market Size YoY Growth 2019-2030

8.2 China Hyperimmune Globulins Sales in Volume, by Type (2019, 2023 & 2030)

8.3 China Hyperimmune Globulins Sales in Volume, by Application (2019, 2023 & 2030)

9 APAC

9.1 APAC Hyperimmune Globulins Market Size YoY Growth 2019-2030

9.2 APAC Hyperimmune Globulins Sales in Volume, by Type (2019, 2023 & 2030)

9.3 APAC Hyperimmune Globulins Sales in Volume, by Application (2019, 2023 & 2030)

9.4 APAC Hyperimmune Globulins Market Facts & Figures by Country (2019, 2023 & 2030)

9.4.1 APAC Hyperimmune Globulins Sales in Value by Country (2019, 2023 & 2030)

9.4.2 APAC Hyperimmune Globulins Sales in Volume by Country (2019, 2023 & 2030)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 CSL Behring

10.1.1 CSL Behring Company Information

10.1.2 CSL Behring Description and Business Overview

10.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.1.4 CSL Behring Hyperimmune Globulins Products Offered

10.1.5 CSL Behring Recent Development

10.2 Grifols

10.2.1 Grifols Company Information

10.2.2 Grifols Description and Business Overview

10.2.3 Grifols Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.2.4 Grifols Hyperimmune Globulins Products Offered

10.2.5 Grifols Recent Development

10.3 Biotest

10.3.1 Biotest Company Information

10.3.2 Biotest Description and Business Overview

10.3.3 Biotest Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.3.4 Biotest Hyperimmune Globulins Products Offered

10.3.5 Biotest Recent Development

10.4 Kedrion

10.4.1 Kedrion Company Information

10.4.2 Kedrion Description and Business Overview

10.4.3 Kedrion Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.4.4 Kedrion Hyperimmune Globulins Products Offered

10.4.5 Kedrion Recent Development

10.5 CBPO

10.5.1 CBPO Company Information

10.5.2 CBPO Description and Business Overview

10.5.3 CBPO Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.5.4 CBPO Hyperimmune Globulins Products Offered

10.5.5 CBPO Recent Development

10.6 Emergent (Cangene)

10.6.1 Emergent (Cangene) Company Information

10.6.2 Emergent (Cangene) Description and Business Overview

10.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.6.4 Emergent (Cangene) Hyperimmune Globulins Products Offered

10.6.5 Emergent (Cangene) Recent Development

10.7 Kamada

10.7.1 Kamada Company Information

10.7.2 Kamada Description and Business Overview

10.7.3 Kamada Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.7.4 Kamada Hyperimmune Globulins Products Offered

10.7.5 Kamada Recent Development

10.8 CNBG

10.8.1 CNBG Company Information

10.8.2 CNBG Description and Business Overview

10.8.3 CNBG Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.8.4 CNBG Hyperimmune Globulins Products Offered

10.8.5 CNBG Recent Development

10.9 Hualan Bio

10.9.1 Hualan Bio Company Information

10.9.2 Hualan Bio Description and Business Overview

10.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.9.4 Hualan Bio Hyperimmune Globulins Products Offered

10.9.5 Hualan Bio Recent Development

10.10 Shanghai RAAS

10.10.1 Shanghai RAAS Company Information

10.10.2 Shanghai RAAS Description and Business Overview

10.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.10.4 Shanghai RAAS Hyperimmune Globulins Products Offered

10.10.5 Shanghai RAAS Recent Development

10.11 Sichuan Yuanda Shuyang

10.11.1 Sichuan Yuanda Shuyang Company Information

10.11.2 Sichuan Yuanda Shuyang Description and Business Overview

10.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Products Offered

10.11.5 Sichuan Yuanda Shuyang Recent Development

10.12 ADMA Biologics

10.12.1 ADMA Biologics Company Information

10.12.2 ADMA Biologics Description and Business Overview

10.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

10.12.4 ADMA Biologics Hyperimmune Globulins Products Offered

10.12.5 ADMA Biologics Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Hyperimmune Globulins Industry Chain Analysis

11.2 Hyperimmune Globulins Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Hyperimmune Globulins Production Mode & Process

11.4 Hyperimmune Globulins Sales and Marketing

11.4.1 Hyperimmune Globulins Sales Channels

11.4.2 Hyperimmune Globulins Distributors

11.5 Hyperimmune Globulins Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Hyperimmune Globulins CAGR in Value, Japan VS Global, 2019 VS 2023 VS 2030

Table 2. Hyperimmune Globulins Market Trends

Table 3. Hyperimmune Globulins Market Drivers

Table 4. Hyperimmune Globulins Market Challenges

Table 5. Hyperimmune Globulins Market Restraints

Table 6. Global Hyperimmune Globulins Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Japan Hyperimmune Globulins Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Hyperimmune Globulins Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. Japan Hyperimmune Globulins Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Key Manufacturers of Hyperimmune Globulins, Ranked by Revenue (2023) & (US$ Million)

Table 11. Global Hyperimmune Globulins Revenue by Manufacturer, (US$ Million) & (2019-2024)

Table 12. Global Hyperimmune Globulins Revenue Share by Manufacturer, 2019-2024

Table 13. Global Hyperimmune Globulins Sales by Manufacturer, (K Units), 2019-2024

Table 14. Global Hyperimmune Globulins Sales Share by Manufacturer, 2019-2024

Table 15. Global Hyperimmune Globulins Price by Manufacturer (2019-2024) & (USD/Unit)

Table 16. Global Hyperimmune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Hyperimmune Globulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Globulins as of 2023)

Table 18. Global Key Manufacturers of Hyperimmune Globulins, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Hyperimmune Globulins, Product Offered and Application

Table 20. Global Key Manufacturers of Hyperimmune Globulins, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Hyperimmune Globulins in Japan, Ranked by Revenue (2023) & (US$ million)

Table 23. Japan Hyperimmune Globulins Revenue by Players, (US$ Million) & (2019-2024)

Table 24. Japan Hyperimmune Globulins Revenue Share by Players, (2019-2024)

Table 25. Japan Hyperimmune Globulins Sales by Players, (K Units) & (2019-2024)

Table 26. Japan Hyperimmune Globulins Sales Share by Players, (2019-2024)

Table 27. Global Hyperimmune Globulins Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 28. Global Hyperimmune Globulins Sales in Volume by Region (2019-2024) & (K Units)

Table 29. Global Hyperimmune Globulins Sales in Volume Forecast by Region (2025-2030) & (K Units)

Table 30. Global Hyperimmune Globulins Sales in Value by Region (2019-2024) & (US$ Million)

Table 31. Global Hyperimmune Globulins Sales in Value Forecast by Region (2025-2030) & (US$ Million)

Table 32. Americas Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. Americas Hyperimmune Globulins Sales in Value by Country (2019-2024) & (US$ Million)

Table 34. Americas Hyperimmune Globulins Sales in Value by Country (2025-2030) & (US$ Million)

Table 35. Americas Hyperimmune Globulins Sales in Volume by Country (2019-2024) & (K Units)

Table 36. Americas Hyperimmune Globulins Sales in Volume by Country (2025-2030) & (K Units)

Table 37. EMEA Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. EMEA Hyperimmune Globulins Sales in Value by Country (2019-2024) & (US$ Million)

Table 39. EMEA Hyperimmune Globulins Sales in Value by Country (2025-2030) & (US$ Million)

Table 40. EMEA Hyperimmune Globulins Sales in Volume by Country (2019-2024) & (K Units)

Table 41. EMEA Hyperimmune Globulins Sales in Volume by Country (2025-2030) & (K Units)

Table 42. APAC Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. APAC Hyperimmune Globulins Sales in Value by Country (2019-2024) & (US$ Million)

Table 44. APAC Hyperimmune Globulins Sales in Value by Country (2025-2030) & (US$ Million)

Table 45. APAC Hyperimmune Globulins Sales in Volume by Country (2019-2024) & (K Units)

Table 46. APAC Hyperimmune Globulins Sales in Volume by Country (2025-2030) & (K Units)

Table 47. CSL Behring Company Information

Table 48. CSL Behring Description and Business Overview

Table 49. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 50. CSL Behring Hyperimmune Globulins Product

Table 51. CSL Behring Recent Development

Table 52. Grifols Company Information

Table 53. Grifols Description and Business Overview

Table 54. Grifols Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 55. Grifols Hyperimmune Globulins Product

Table 56. Grifols Recent Development

Table 57. Biotest Company Information

Table 58. Biotest Description and Business Overview

Table 59. Biotest Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Biotest Hyperimmune Globulins Product

Table 61. Biotest Recent Development

Table 62. Kedrion Company Information

Table 63. Kedrion Description and Business Overview

Table 64. Kedrion Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Kedrion Hyperimmune Globulins Product

Table 66. Kedrion Recent Development

Table 67. CBPO Company Information

Table 68. CBPO Description and Business Overview

Table 69. CBPO Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. CBPO Hyperimmune Globulins Product

Table 71. CBPO Recent Development

Table 72. Emergent (Cangene) Company Information

Table 73. Emergent (Cangene) Description and Business Overview

Table 74. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Emergent (Cangene) Hyperimmune Globulins Product

Table 76. Emergent (Cangene) Recent Development

Table 77. Kamada Company Information

Table 78. Kamada Description and Business Overview

Table 79. Kamada Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Kamada Hyperimmune Globulins Product

Table 81. Kamada Recent Development

Table 82. CNBG Company Information

Table 83. CNBG Description and Business Overview

Table 84. CNBG Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. CNBG Hyperimmune Globulins Product

Table 86. CNBG Recent Development

Table 87. Hualan Bio Company Information

Table 88. Hualan Bio Description and Business Overview

Table 89. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Hualan Bio Hyperimmune Globulins Product

Table 91. Hualan Bio Recent Development

Table 92. Shanghai RAAS Company Information

Table 93. Shanghai RAAS Description and Business Overview

Table 94. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Shanghai RAAS Hyperimmune Globulins Product

Table 96. Shanghai RAAS Recent Development

Table 97. Sichuan Yuanda Shuyang Company Information

Table 98. Sichuan Yuanda Shuyang Description and Business Overview

Table 99. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Sichuan Yuanda Shuyang Hyperimmune Globulins Product

Table 101. Sichuan Yuanda Shuyang Recent Development

Table 102. ADMA Biologics Company Information

Table 103. ADMA Biologics Description and Business Overview

Table 104. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. ADMA Biologics Hyperimmune Globulins Product

Table 106. ADMA Biologics Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Hyperimmune Globulins Distributors List

Table 110. Hyperimmune Globulins Customers List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Hyperimmune Globulins Product Picture

Figure 2. Global Hyperimmune Globulins Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 3. Global Hyperimmune Globulins Market Size 2019-2030 (US$ Million)

Figure 4. Global Hyperimmune Globulins Sales 2019-2030 (K Units)

Figure 5. Japan Hyperimmune Globulins Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 6. Japan Hyperimmune Globulins Market Size 2019-2030 (US$ Million)

Figure 7. Japan Hyperimmune Globulins Sales 2019-2030 (K Units)

Figure 8. Japan Hyperimmune Globulins Market Share in Global, in Value (US$ Million) 2019-2030

Figure 9. Japan Hyperimmune Globulins Market Share in Global, in Volume (K Units) 2019-2030

Figure 10. Hyperimmune Globulins Report Years Considered

Figure 11. Product Picture of Hepatitis B Immunoglobulins

Figure 12. Product Picture of Rabies Immunoglobulins

Figure 13. Product Picture of Tetanus Immunoglobulins

Figure 14. Product Picture of Rho(D) Immunoglobulins

Figure 15. Product Picture of Herpes Zoster Immune Globulin

Figure 16. Product Picture of Other

Figure 17. Global Hyperimmune Globulins Market Share by Type in 2023 & 2030

Figure 18. Global Hyperimmune Globulins Sales in Value by Type (2019-2030) & (US$ Million)

Figure 19. Global Hyperimmune Globulins Sales Market Share in Value by Type (2019-2030)

Figure 20. Global Hyperimmune Globulins Sales by Type (2019-2030) & (K Units)

Figure 21. Global Hyperimmune Globulins Sales Market Share in Volume by Type (2019-2030)

Figure 22. Global Hyperimmune Globulins Price by Type (2019-2030) & (USD/Unit)

Figure 23. Japan Hyperimmune Globulins Market Share by Type in 2023 & 2030

Figure 24. Japan Hyperimmune Globulins Sales in Value by Type (2019-2030) & (US$ Million)

Figure 25. Japan Hyperimmune Globulins Sales Market Share in Value by Type (2019-2030)

Figure 26. Japan Hyperimmune Globulins Sales by Type (2019-2030) & (K Units)

Figure 27. Japan Hyperimmune Globulins Sales Market Share in Volume by Type (2019-2030)

Figure 28. Japan Hyperimmune Globulins Price by Type (2019-2030) & (USD/Unit)

Figure 29. Product Picture of Government Institutions

Figure 30. Product Picture of Private Sector

Figure 31. Product Picture of Other

Figure 32. Global Hyperimmune Globulins Market Share by Application in 2023 & 2030

Figure 33. Global Hyperimmune Globulins Sales in Value by Application (2019-2030) & (US$ Million)

Figure 34. Global Hyperimmune Globulins Sales Market Share in Value by Application (2019-2030)

Figure 35. Global Hyperimmune Globulins Sales by Application (2019-2030) & (K Units)

Figure 36. Global Hyperimmune Globulins Sales Market Share in Volume by Application (2019-2030)

Figure 37. Global Hyperimmune Globulins Price by Application (2019-2030) & (USD/Unit)

Figure 38. Japan Hyperimmune Globulins Market Share by Application in 2023 & 2030

Figure 39. Japan Hyperimmune Globulins Sales in Value by Application (2019-2030) & (US$ Million)

Figure 40. Japan Hyperimmune Globulins Sales Market Share in Value by Application (2019-2030)

Figure 41. Japan Hyperimmune Globulins Sales by Application (2019-2030) & (K Units)

Figure 42. Japan Hyperimmune Globulins Sales Market Share in Volume by Application (2019-2030)

Figure 43. Japan Hyperimmune Globulins Price by Application (2019-2030) & (USD/Unit)

Figure 44. The Top 5 and 10 Largest Manufacturers of Hyperimmune Globulins in the World: Market Share by Hyperimmune Globulins Revenue in 2023

Figure 45. Global Hyperimmune Globulins Market Size Market Share by Region: 2019 VS 2023 VS 2030

Figure 46. Global Hyperimmune Globulins Sales in Volume Market Share by Region (2019-2030)

Figure 47. Global Hyperimmune Globulins Sales in Value Market Share by Region (2019-2030)

Figure 48. Americas Hyperimmune Globulins Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 49. Americas Hyperimmune Globulins Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 50. Americas Hyperimmune Globulins Sales by Type (2019-2030) & (K Units)

Figure 51. Americas Hyperimmune Globulins Sales Market Share in Volume by Type (2019-2030)

Figure 52. Americas Hyperimmune Globulins Sales by Application (2019-2030) & (K Units)

Figure 53. Americas Hyperimmune Globulins Sales Market Share in Volume by Application (2019-2030)

Figure 54. United States Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 55. Canada Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 56. Mexico Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 57. Brazil Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 58. EMEA Hyperimmune Globulins Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 59. EMEA Hyperimmune Globulins Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 60. EMEA Hyperimmune Globulins Sales by Type (2019-2030) & (K Units)

Figure 61. EMEA Hyperimmune Globulins Sales Market Share in Volume by Type (2019-2030)

Figure 62. EMEA Hyperimmune Globulins Sales by Application (2019-2030) & (K Units)

Figure 63. EMEA Hyperimmune Globulins Sales Market Share in Volume by Application (2019-2030)

Figure 64. Europe Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 65. Middle East Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 66. Africa Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 67. China Hyperimmune Globulins Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 68. China Hyperimmune Globulins Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 69. China Hyperimmune Globulins Sales by Type (2019-2030) & (K Units)

Figure 70. China Hyperimmune Globulins Sales Market Share in Volume by Type (2019-2030)

Figure 71. China Hyperimmune Globulins Sales by Application (2019-2030) & (K Units)

Figure 72. China Hyperimmune Globulins Sales Market Share in Volume by Application (2019-2030)

Figure 73. APAC Hyperimmune Globulins Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 74. APAC Hyperimmune Globulins Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 75. APAC Hyperimmune Globulins Sales by Type (2019-2030) & (K Units)

Figure 76. APAC Hyperimmune Globulins Sales Market Share in Volume by Type (2019-2030)

Figure 77. APAC Hyperimmune Globulins Sales by Application (2019-2030) & (K Units)

Figure 78. APAC Hyperimmune Globulins Sales Market Share in Volume by Application (2019-2030)

Figure 79. Japan Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 80. South Korea Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 81. China Taiwan Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 82. Southeast Asia Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 83. India Hyperimmune Globulins Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 84. Hyperimmune Globulins Value Chain

Figure 85. Hyperimmune Globulins Production Process

Figure 86. Channels of Distribution (Direct Vs Distribution)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Hyperimmune Globulins market size from 2024 to 2030? zhanKai

The annual compound growth rate of the global Hyperimmune Globulins market is 7% 2024 to 2030.

What was the global market size of Hyperimmune Globulins in 2024? shouQi

What was the global market size of Hyperimmune Globulins in 2030? shouQi

Which companies rank high in the global Hyperimmune Globulins market? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Hyperimmune Globulins Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hyperimmune Globulins market size was US$ 2058 million in 2025 and is forecast to reach a readjusted size of US$ 3284 million by 2032 with a CAGR of 7.0% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 91
USD 4250.00
(Single User License)
Global Hyperimmune Globulins Market Research Report 2026
The global Hyperimmune Globulins market was valued at US$ 2058 million in 2025 and is anticipated to reach US$ 3284 million by 2032, at a CAGR of 7.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 2900.00
(Single User License)
Hyperimmune Globulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hyperimmune Globulins was estimated to be worth US$ 2058 million in 2025 and is projected to reach US$ 3284 million, growing at a CAGR of 7.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 115
USD 3950.00
(Single User License)
Global Hyperimmune Globulins Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hyperimmune Globulins market is projected to grow from US$ 1936 million in 2024 to US$ 3089 million by 2031, at a CAGR of 7.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 164
USD 4900.00
(Single User License)
Global Hyperimmune Globulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hyperimmune Globulins was estimated to be worth US$ 1936 million and is forecast to reach approximately US$ 3089 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 141
USD 5900.00
(Single User License)
Global Hyperimmune Globulins Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hyperimmune Globulins market size was US$ 1936 million in 2024 and is forecast to a readjusted size of US$ 3089 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 95
USD 4250.00
(Single User License)
Hyperimmune Globulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hyperimmune Globulins was estimated to be worth US$ 1936 million in 2024 and is forecast to a readjusted size of US$ 3089 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 113
USD 3950.00
(Single User License)
Global Hyperimmune Globulins Market Research Report 2025
The global market for Hyperimmune Globulins was valued at US$ 1936 million in the year 2024 and is projected to reach a revised size of US$ 3089 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Published Date: 2025-01-16
Pages: 97
USD 2900.00
(Single User License)
Hyperimmune Globulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously. Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Published Date: 2024-09-05
Pages: 129
USD 3950.00
(Single User License)
Global Hyperimmune Globulins Market Insights, Forecast to 2030
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously. Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Published Date: 2024-09-05
Pages: 160
USD 4900.00
(Single User License)

Global Hyperimmune Globulins Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hyperimmune Globulins market size was US$ 2058 million in 2025 and is forecast to reach a readjusted size of US$ 3284 million by 2032 with a CAGR of 7.0% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 91
USD 4250.00 (Single User License)
Global Hyperimmune Globulins Market Research Report 2026
The global Hyperimmune Globulins market was valued at US$ 2058 million in 2025 and is anticipated to reach US$ 3284 million by 2032, at a CAGR of 7.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
USD 2900.00 (Single User License)
Hyperimmune Globulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hyperimmune Globulins was estimated to be worth US$ 2058 million in 2025 and is projected to reach US$ 3284 million, growing at a CAGR of 7.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 115
USD 3950.00 (Single User License)
Global Hyperimmune Globulins Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hyperimmune Globulins market is projected to grow from US$ 1936 million in 2024 to US$ 3089 million by 2031, at a CAGR of 7.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 164
USD 4900.00 (Single User License)
Global Hyperimmune Globulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hyperimmune Globulins was estimated to be worth US$ 1936 million and is forecast to reach approximately US$ 3089 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 141
USD 5900.00 (Single User License)
Global Hyperimmune Globulins Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hyperimmune Globulins market size was US$ 1936 million in 2024 and is forecast to a readjusted size of US$ 3089 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 95
USD 4250.00 (Single User License)
Hyperimmune Globulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hyperimmune Globulins was estimated to be worth US$ 1936 million in 2024 and is forecast to a readjusted size of US$ 3089 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 113
USD 3950.00 (Single User License)
Global Hyperimmune Globulins Market Research Report 2025
The global market for Hyperimmune Globulins was valued at US$ 1936 million in the year 2024 and is projected to reach a revised size of US$ 3089 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Published: 2025-01-16
Pages: 97
USD 2900.00 (Single User License)
Hyperimmune Globulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously. Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Published: 2024-09-05
Pages: 129
USD 3950.00 (Single User License)
Global Hyperimmune Globulins Market Insights, Forecast to 2030
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously. Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Published: 2024-09-05
Pages: 160
USD 4900.00 (Single User License)